This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Prime Therapeutics Receives Innovators In Business Award For 2012 From Florida Governor Rick Scott

ST. PAUL, Minn. , Dec. 21, 2012 /PRNewswire/ -- Prime Therapeutics (Prime) has been awarded the 2012 Innovators in Business – Governor's Newcomer Award by Florida Governor Rick Scott for the outstanding contributions of Prime Therapeutics Specialty Pharmacy to the state's economic growth. Prime was honored during an evening reception at the Florida Governor's mansion in Tallahassee, FL on Dec. 10, 2012.

"We are pleased to see our commitment to the economic development of this region recognized through this prominent award," said Eric Elliott, president and CEO of Prime. "We are proud of the 122 professionals currently employed at Prime Specialty Pharmacy who are dedicated to providing our members easier access to more affordable medicines so they can feel better and live well."   

The Governor's Innovators in Business Awards recognize outstanding contributions toward improving and diversifying Florida's economy plus distinctive community investment efforts, particularly relating to industries targeted for economic development and high wage job growth.  

"My number one mission is to grow jobs for Florida families, and the successes these companies have experienced represent the job opportunities being created in Florida," said Governor Rick Scott.

Prime Specialty Pharmacy is expanding the company's ability to manage specialty medicine functions and is projected to create 213 new jobs for the region over the next three years.  Medications managed and delivered by the specialty pharmacy are often used to treat complex and chronic conditions such as multiple sclerosis, hepatitis C and cancer. The facility has been operating since early August with specialty pharmacy order processing, care management, fulfillment, billing and customer service.

About Prime Therapeutics Prime Therapeutics, a leader in pharmacy benefit management, is dedicated to making it easier for our nearly 20 million members to obtain more affordable medicines. We leverage our unique connections to deliver programs that lead to the best health outcomes for our members.

Headquartered in St. Paul, Minn., Prime Therapeutics serves nearly 20 million people and is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans.

For more information, visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.

SOURCE Prime Therapeutics

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs